Lipid Lowering in “Very High Risk” Patients Undergoing Coronary Artery Bypass Surgery and Its Projected Reduction in Risk for Recurrent Vascular Events: A Monte Carlo Stepwise Simulation Approach-Reference-Cited by-同舟云学术

Lipid Lowering in “Very High Risk” Patients Undergoing Coronary Artery Bypass Surgery and Its Projected Reduction in Risk for Recurrent Vascular Events: A Monte Carlo Stepwise Simulation Approach

Published:2023-02 Issue:2 Volume:81 Page:120-128
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Deo Salil,Ueda Peter,Sheikh Adil Muhammad,Altarabsheh Salah,Elgudin Yakov,Rubelowsky Joseph,Cmolik Brian,Hawkins Neil,McAllister David,Ruel Marc,Sattar Naveed,Pell Jill

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference21 articles.

1. Trends in characteristics and outcomes of hospitalized young patients undergoing coronary artery bypass grafting in the United States, 2004 to 2018;Dani;J Am Heart Assoc.,2021

2. Stability after initial decline in coronary revascularization rates in the United States;Raza;Ann Thorac Surg.,2019

3. Coronary artery bypass graft versus percutaneous coronary intervention: meds matter: impact of adherence to medical therapy on comparative outcomes;Kurlansky;Circulation,2016

4. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association;Kulik;Circulation,2015

5. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American college of Cardiology/American Heart association task force on clinical practice guidelines;Grundy;Circulation,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel therapies to achieve the recommended low-density lipoprotein cholesterol concentration (LDL-C) targets for patients after coronary artery bypass grafting;The Journal of Thoracic and Cardiovascular Surgery;2024-02

2. Validating the SMART2 Score in a Racially Diverse High‐Risk Nationwide Cohort of Patients Receiving Coronary Artery Bypass Grafting;Journal of the American Heart Association;2023-11-07

3. Monte Carlo simulations to meet the ESC recommended low-density lipoprotein cholesterol targets;The Lancet Regional Health - Europe;2023-08

4. Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study;The Lancet Regional Health - Europe;2023-08